| Nov 13 |
ProPhase Labs reports mixed Q3 results; initiates Q424 soft outlook
|
| Nov 13 |
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 13 |
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024
|
| Nov 13 |
Earnings Scheduled For November 13, 2024
|
| Nov 12 |
ProPhase Labs files for mixed shelf offering
|
| Nov 12 |
ProPhase Labs Announces Closing of Public Offering of Common Stock
|
| Nov 11 |
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
|
| Nov 8 |
Top Midday Decliners
|
| Nov 8 |
ProPhase Labs plummets 21%, prices $3M equity offering
|
| Nov 8 |
ProPhase Labs Announces Pricing of Public Offering of Common Stock
|
